Library

2011 Survey of Health Care Consumers Global Report / Deloitte Center for Health Solutions / Deloitte Development (2011)  

2011 Survey of Health Care Consumers Global Report : Key Findings, Strategic Implications [printed text] / Deloitte Center for Health Solutions, Author . - Deloitte Development, 2011 . - 40 p. Languages : English (eng) Descriptors: Classification WA 900 Public health statistics (including narrative reports on health conditions and health surveys) Indexation Belgium ; Brazil ; Canada ; China ; France ; Germany ; Great Britain ; Health Policy ; Health Services ; Health Surveys ; Insurance, Health ; Luxembourg ; Patient Satisfaction ; Patients ; Portugal ; statistics and numerical data [Subheading] ; Switzerland ; United States ; utilization Contents note: Foreword 3 -- Introduction 4 -- Survey highlights 10 -- Major findings 34 -- Stakeholder implications 35 -- Closing thoughts 36 -- Contacts 37 Link for e-copy: http://www.deloitte.com/assets/Dcom-UnitedStates/Local%20Assets/Documents/US_CHS [...] Format of e-copy: pdf Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=2688

Capaciteitsplanning in de zorg / Bart Berden / Berlin : Springer (2016)

Capaciteitsplanning in de zorg [printed text] / Bart Berden, Author ; Léo Berrevoets ; Windi Winasti, Author . - Berlin : Springer, 2016 . - 286 p. : ill., ; 25 cm. ISBN : 978-90-368-1339-6 Languages : Dutch (dut) Descriptors: Classification WA 525 Health Administration and Organization - General works Indexation Patient Care Management ; Patient Compliance ; Patient Satisfaction ; Physician-Patient Relations ; Risk Management Abstract: Het uitgangspunt van dit boek is goede patiëntenzorg, kostenbeheersing en aantrekkelijk werkgeverschap. Zorg wordt geleverd door mensen. Een tevreden of ontevreden patiënt oordeelt vooral op basis van de inzet en het handelen van zorgverleners. Een zorginstelling bestaat, voor alles, uit medewerkers en niet uit apparatuur, stenen of (gratis) parkeerplaatsen. Het belang van de medewerker heeft geleid tot toenemende aandacht voor het personeelsbeleid. Dat geldt voor de volle breedte, van werving en selectie, matching van taken en competenties tot en met continue scholing en toetsing. Naar verhouding is er minder aandacht voor de planning van de inzet van medewerkers. Dat roept verbazing op. Een niet passende bezetting heeft aanzienlijke consequenties: via de niet gemotiveerde, onder- of overbelaste medewerkers kan het leiden tot mindere kwaliteit van zorg. Ook is het een directe aanslag op de doelmatigheid van de onderneming. Het is deze constatering die de verantwoording vormt voor het onderwerp van dit boek. Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=4482

Hold

Place a hold on this item

Copies(1)

Barcode	Call number	Media type	Location	Section	Status
10273-03387	WA 525 / BER	Book	KCE	Library (10.124)	Due for return by 09/30/2026

Readers who borrowed this document also borrowed:

Arts in het ziekenhuis	De Witte, Karel
Goed ziek	De Ridder, R.
BADS Directory of Procedures
The system of care handbook	Stroul, Beth A.
The innovator's prescription	Christensen, Clayton M.
Gezondheidseconomie voor niet-economen	Annemans, Lieven
Learning for action	Checkland, Peter
Complex Interventions in Health	Richards, David A.
Safety in Numbers	Gordon, Suzanne
Emergency care and the public's health	Pines, Jesse M.
Big Data-Enabled Nursing	Delaney, C.W

Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine/caffeine in migraine / S. Christie in European Neurology, 49(2003)01 ([01/01/2003])  

[article] Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine/caffeine in migraine [printed text] / S. Christie, Author ; H. Gobel, Author ; V. Mateos, Author ; C. Allen, Author ; France Vrijens , Author ; M. Shivaprakash, Author . - 2003 . - p.20-29. Languages : English (eng) in European Neurology > 49(2003)01 [01/01/2003] . - p.20-29 Descriptors: Classification W 1 Serials. Periodicals Indexation Adolescent ; Adult ; Aged ; Cross-Sectional Studies ; Double-Blind Method ; Drug Combinations ; Journal Article ; Migraine Disorders ; Pain Measurement ; Patient Satisfaction ; Peer Review Abstract: Rizatriptan is a selective 5-HT(1B/1D) receptor agonist with rapid oral absorption and early onset of action in the acute treatment of migraine. This randomized double- blind crossover outpatient study assessed the preference for 1 rizatriptan 10 mg tablet to 2 ergotamine 1 mg/caffeine 100 mg tablets in 439 patients treating a single migraine attack with each therapy. Of patients expressing a preference (89.1%), more than twice as many preferred rizatriptan to ergotamine/caffeine (69.9 vs. 30.1%, p < or = 0.001). Faster relief of headache was the most important reason for preference, cited by 67.3% of patients preferring rizatriptan and 54.2% of patients who preferred ergotamine/caffeine. The co-primary endpoint of being pain free at 2 h was also in favor of rizatriptan. Forty-nine percent of patients were pain free 2 h after rizatriptan, compared with 24.3% treated with ergotamine/caffeine (p < or = 0.001), rizatriptan being superior within 1 h of treatment. Headache relief at 2 h was 75.9% for rizatriptan and 47.3% for ergotamine/caffeine (p < or = 0.001), with rizatriptan being superior to ergotamine/caffeine within 30 min of dosing. Almost 36% of patients taking rizatriptan were pain free at 2 h and had no recurrence or need for additional medication within 24 h, compared to 20% of patients on ergotamine/caffeine (p < or = 0.001). Rizatriptan was also superior to ergotamine/caffeine in the proportions of patients with no nausea, vomiting, phonophobia or photophobia and for patients with normal function 2 h after drug intake (p < or = 0.001). More patients were (completely, very or somewhat) satisfied 2 h after treatment with rizatriptan (69.8%) than at 2 h after treatment with ergotamine/caffeine (38.6%, p < or = 0.001). Recurrence rates were 31.4% with rizatriptan and 15.3% with ergotamine/caffeine. Both active treatments were well tolerated. The most common adverse events (incidence > or = 5% in one group) after rizatriptan and ergotamine/caffeine, respectively, were dizziness (6.7 and 5.3%), nausea (4.2 and 8.5%) and somnolence (5.5 and 2.3%). Link for e-copy: https://doi.org/10.1159/000067018 Format of e-copy: PDF [Requires Subscription] Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=4092 [article]

Measuring patient-reported outcomes in solid organ transplant recipients / Irina Cleemput in Pharmacoeconomics, 25(2007)4 ([04/01/2007])  

[article] Measuring patient-reported outcomes in solid organ transplant recipients : an overview of instruments developed to date [printed text] / Irina Cleemput , Author ; F. Dobbels, Author . - 2007 . - 269-286. Languages : English (eng) in Pharmacoeconomics > 25(2007)4 [04/01/2007] . - 269-286 Descriptors: Classification W 1 Serials. Periodicals Indexation Great Britain ; Humans ; Journal Article ; Patient Satisfaction ; Peer Review ; Psychometrics ; Quality of Life ; Transplants ; Treatment outcome Abstract: Improvements in organ preservation methods, immunosuppressive regimens and general post-transplant care have resulted in an increased life expectancy and a continually decreasing morbidity after solid organ transplantation. As attention gradually moves towards improving subjective patient outcomes, the use of patient-reported outcome measures (PROs) thus becomes increasingly important in post-transplant patient management. This paper provides a brief systematic overview of the transplant-specific PRO measures, and their psychometric properties, developed and used in solid organ transplant recipients to date. PRO measures may focus on or encompass different aspects of life relevant to organ transplant patients: overall quality of life (QOL), physical, psychological and social functioning, and adherence. Overall QOL can be measured using transplant-specific or generic QOL instruments, or a combination of both. In general, very little information is available on the psychometric properties of PRO measures, and there is no gold standard for PRO measurement. Transplant-specific and generic PRO instruments are complementary. Generic instruments will continue to be important for economic evaluations, but transplant-specific instruments may be more useful for patient management purposes, as they are generally more sensitive to small but clinically relevant changes in outcomes in transplant populations. Link for e-copy: http://adisonline.com/pharmacoeconomics/pages/default.aspx Format of e-copy: PDF [Requires Subscription] Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=2437 [article]